Position:Home> News> Our News


Baheal Pharm joins hands with the World Associations of Chinese Doctors  to fight the epidemic

Though separated by a mountain, we’ll share the same clouds and rain. The bright moon belongs not to a single town. Although the domestic epidemic has gradually eased, the global spread of the COVID-19 still affects the hearts ...


Baheal produced the anti-epidemic publicity film "Angel's Voice" to pay tribute to the "angels in white" on the front line of anti-epidemic!

Facing the epidemic, They gave up the opportunity to reunite with their family, Fight on the front lines of the epidemic. Baheal Pharmaceutical Group specially produced the anti-epidemic video "Angel's Voice", Chairman Fu Gang ...


Baheal Pharm signed a cloud contract with Mylan to deepen cooperation in the field of bone health

On March 4, Baheal Pharm and Mylan, the world's largest generic drug supplier, reached a "screen-to-screen" cooperation on the cloud. "Baheal Pharm officially became the sole general agent of the Glucosamine Sulfate Capsules Vi...


Baheal Pharm's commercialization platform adds new partners to expand eye drug retail market with Relin Pharmaceutical

On January 10, Baheal Pharm and Relin Pharmaceutical , a professional academic promotion company in the ophthalmology field, reached a strategic cooperation in the retail market. Zhu Xiaowei, director of Baheal Pharmaceutical G...


Updated cooperation between Baheal and Itochu witnesses the expanded economic cooperation between Chinese and Japanese companies in Shandong

To accelerate the shift in driving forces of development, and to put “investment promotion and talent recruitment” into action, GONG Zheng, the Governor of Shandong Province led a delegation to visit Japan, and carried out an o...


Chinese pharmaceutical preparation technology challenges international patents – major breakthrough achieved by Baheal Pharmaceutical

Qingdao Baheal Pharmaceutical Ltd. recently announced that, its advanced generics preparation technology has achieved major breakthrough, and Nida, an osmotic-controlled metformin-based diabetes medicine has been approved by FD...